A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
Clinical trial NCT02480153 · COMPLETED
Trial details
- NCT number
- NCT02480153
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-25
- Primary completion
- 2016-08-31
- Enrollment
- 597
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.